Targeting cerebral Bcl-2 expression as a potential therapeutic target in autism: potential usefulness of human recombinant nerve growth factor

Med Hypotheses. 2006;67(5):1256-7. doi: 10.1016/j.mehy.2006.06.003. Epub 2006 Aug 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Autistic Disorder / drug therapy*
  • Autistic Disorder / genetics
  • Brain / physiopathology
  • Disease Models, Animal
  • Humans
  • Nerve Growth Factor / genetics
  • Nerve Growth Factor / therapeutic use*
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • Recombinant Proteins / therapeutic use

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • Recombinant Proteins
  • Nerve Growth Factor